IOL CHEMICALS & PHARM. | SHUKRA PHARMA | IOL CHEMICALS & PHARM./ SHUKRA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 22.1 | 61.9% | View Chart |
P/BV | x | 1.6 | 16.2 | 9.6% | View Chart |
Dividend Yield | % | 1.0 | 0.5 | 187.1% |
IOL CHEMICALS & PHARM. SHUKRA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SHUKRA PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ SHUKRA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 89 | 605.1% | |
Low | Rs | 272 | 11 | 2,447.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 53.7 | 703.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 4.0 | 589.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 5.7 | 554.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.50 | 800.0% | |
Avg Dividend yield | % | 1.0 | 1.0 | 98.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 23.1 | 1,112.6% | |
Shares outstanding (eoy) | m | 58.71 | 10.96 | 535.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.9 | 115.2% | |
Avg P/E ratio | x | 17.1 | 12.4 | 137.5% | |
P/CF ratio (eoy) | x | 12.8 | 8.8 | 146.3% | |
Price / Book Value ratio | x | 1.6 | 2.2 | 72.8% | |
Dividend payout | % | 16.9 | 12.4 | 135.7% | |
Avg Mkt Cap | Rs m | 23,743 | 547 | 4,340.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 44 | 3,812.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 588 | 3,768.4% | |
Other income | Rs m | 256 | 12 | 2,139.5% | |
Total revenues | Rs m | 22,427 | 600 | 3,736.0% | |
Gross profit | Rs m | 2,257 | 54 | 4,207.9% | |
Depreciation | Rs m | 462 | 18 | 2,511.4% | |
Interest | Rs m | 165 | 3 | 5,861.2% | |
Profit before tax | Rs m | 1,887 | 44 | 4,247.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 141,457.1% | |
Profit after tax | Rs m | 1,391 | 44 | 3,157.2% | |
Gross profit margin | % | 10.2 | 9.1 | 111.7% | |
Effective tax rate | % | 26.2 | 0.8 | 3,311.9% | |
Net profit margin | % | 6.3 | 7.5 | 83.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 531 | 1,821.4% | |
Current liabilities | Rs m | 5,025 | 425 | 1,182.2% | |
Net working cap to sales | % | 20.9 | 18.0 | 116.6% | |
Current ratio | x | 1.9 | 1.2 | 154.1% | |
Inventory Days | Days | 43 | 0 | - | |
Debtors Days | Days | 8 | 1,873 | 0.4% | |
Net fixed assets | Rs m | 11,017 | 219 | 5,031.9% | |
Share capital | Rs m | 587 | 39 | 1,500.0% | |
"Free" reserves | Rs m | 14,490 | 214 | 6,776.5% | |
Net worth | Rs m | 15,077 | 253 | 5,960.1% | |
Long term debt | Rs m | 0 | 38 | 0.0% | |
Total assets | Rs m | 20,684 | 750 | 2,759.1% | |
Interest coverage | x | 12.5 | 16.8 | 74.1% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.8 | 136.6% | |
Return on assets | % | 7.5 | 6.3 | 120.3% | |
Return on equity | % | 9.2 | 17.4 | 53.0% | |
Return on capital | % | 13.6 | 16.2 | 83.7% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 32 | 3,857.1% | |
From Investments | Rs m | -1,200 | -44 | 2,710.6% | |
From Financial Activity | Rs m | -41 | 49 | -83.2% | |
Net Cashflow | Rs m | -18 | 37 | -49.9% |
Indian Promoters | % | 48.2 | 51.0 | 94.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,545.5% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.0 | 105.6% | |
Shareholders | 130,003 | 12,974 | 1,002.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | RELISH PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.08% | 1.97% | 0.57% |
1-Month | 5.72% | 9.88% | 2.66% |
1-Year | -2.67% | 327.40% | 56.32% |
3-Year CAGR | -12.89% | 161.08% | 15.26% |
5-Year CAGR | 16.81% | 96.81% | 19.66% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the RELISH PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of RELISH PHARMA the stake stands at 51.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of RELISH PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
RELISH PHARMA paid Rs 0.5, and its dividend payout ratio stood at 12.4%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of RELISH PHARMA.
For a sector overview, read our pharmaceuticals sector report.
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.